TradeUP Acquisition (UPTD) Stock Price, News & Analysis

Company Overview

TradeUP Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Key Stats

• Today's Range: $1.12 to $1.25
• 50-Day Range: $1.11 to $9.34
• 52-Week Range: $6.88 to $33.00
• Volume: 11,204 shs
• Average Volume: 270,115 shs
• Market Capitalization: $2.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UPTD Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of TradeUP Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TradeUP Acquisition investors own include Xencor (XNCR), Viridian Therapeutics (VRDN), Redwire (RDW), Rocket Pharmaceuticals (RCKT), PFSweb (PFSW), NVIDIA (NVDA) and NICE (NICE).

Company Calendar

• Today: 5/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: N/A
• Current Symbol: NASDAQ:UPTD
• CIK: 1844417
• Web: N/A
• Phone: 732-910-9692
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,000,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -3.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.09
• Quick Ratio: 0.09

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.59) per share
• Price / Book: -0.73

Miscellaneous

• Outstanding Shares: 2,168,000
• Free Float: 973,000
• Market Cap: $2.51 million
• Optionable: Not Optionable
• Beta: 0.12